evidence table
Curcumin Blood Pressure Meta-Analysis Evidence Table
Structured evidence table for Curcumin Blood Pressure Meta-Analysis, generated from 1 reusable source document in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Curcumin Blood Pressure Meta-Analysis | Introduction Hypertension is a major cardiovascular risk factor in individuals with prediabetes and type 2 diabetes (T2D). | 1 | Bahari H (2026) | Antihypertensive Effects of Curcumin/Turmeric Supplementation in Prediabetes and Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. |
| Curcumin Blood Pressure Meta-Analysis | Pooled results indicated that curcumin/turmeric supplementation significantly reduced SBP (WMD: -2.69 mmHg; 95% CI: -3.84 to -1.55; p 2 = 30.1%) compared to control groups. | 1 | Bahari H (2026) | Antihypertensive Effects of Curcumin/Turmeric Supplementation in Prediabetes and Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. |
| Curcumin Blood Pressure Meta-Analysis | However, no significant effect was found on DBP (WMD: -1.20 mmHg; 95% CI: -2.84 to 0.44; p = 0.15; I 2 = 84.3%). | 1 | Bahari H (2026) | Antihypertensive Effects of Curcumin/Turmeric Supplementation in Prediabetes and Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. |
| Curcumin Blood Pressure Meta-Analysis | Curcumin, with its anti-inflammatory and antioxidant properties, has emerged as a potential adjunct therapy, but its effect on blood pressure in this population remains unclear. | 1 | Bahari H (2026) | Antihypertensive Effects of Curcumin/Turmeric Supplementation in Prediabetes and Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. |
Source documents